Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Potential effect of sulindac on response of prothrombin-time to oral anticoagulants.

Carter SA.

Lancet. 1979 Sep 29;2(8144):698-9. No abstract available.

PMID:
90792
2.

Sulindac, prothrombin time, and anticoagulants.

Ross JR, Beeley L.

Lancet. 1979 Nov 17;2(8151):1075. No abstract available.

PMID:
91811
3.

[Coumarin therapy during antirheumatism therapy with sulindac].

Schenk H, Klein G, Haralambus I, Goebel R.

Z Rheumatol. 1980 Mar-Apr;39(3-4):102-8. German.

PMID:
6968485
4.

The potentiation of warfarin anticoagulation by amiodarone.

Hamer A, Peter T, Mandel WJ, Scheinman MM, Weiss D.

Circulation. 1982 May;65(5):1025-9.

PMID:
7074739
5.

Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.

Crowther MA.

Semin Vasc Med. 2003 Aug;3(3):255-60. Review.

PMID:
15199458
6.

Potentiation of oral anticoagulant therapy by acetaminophen.

Antlitz AM, Mead JA Jr, Tolentino MA.

Curr Ther Res Clin Exp. 1968 Oct;10(10):501-7. No abstract available.

PMID:
4971464
7.

Indomethacin or sulindac at night in rheumatoid arthritis.

Schorn D, Seymour MA.

S Afr Med J. 1981 Jun 13;59(25):913-4.

PMID:
7015541
8.

Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.

Cepeláková H, Roubal Z, Grimová J, Dlabac A, Cepelák V.

Acta Univ Carol Med Monogr. 1972;52:55-60. No abstract available.

PMID:
4669827
10.

[Combination therapy with indomethacin and sulindac in chronic polyarthritis].

El-Shohoumi M.

Wien Med Wochenschr. 1982 Sep 15;132(17):399-401. German.

PMID:
7157806
11.

[Sulindac suppositories: treatment of pain in osteoarthritis (author's transl)].

Rampon S, Missioux D, Sarre J.

Sem Hop. 1979 May 18-25;55(19-20):1031-3. French.

PMID:
227091
12.

Some aspects of the pharmacology of oral anticoagulants.

Coon WW, Willis PW 3rd.

Clin Pharmacol Ther. 1970 May-Jun;11(3):312-36. Review. No abstract available.

13.

Warfarin therapy. 2.

Deykin D.

N Engl J Med. 1970 Oct 8;283(15):801-3. Review. No abstract available.

PMID:
4917271
14.

Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate.

Sellers EM, Koch-Weser J.

N Engl J Med. 1970 Oct 15;283(16):827-31. No abstract available.

PMID:
5458032
15.

An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.

Denas G, Cucchini U, Iliceto S, Pengo V.

Thromb Haemost. 2009 Feb;101(2):410-1. No abstract available.

PMID:
19190831
16.

[Long-term multicenter, open label comparative study of sulindac and indomethacin in rheumatoid arthritis (author's transl)].

Shichikawa K, Saito T, Nagaya I, Ogawa N.

Ryumachi. 1982 Apr;22(2):168-84. Japanese. No abstract available.

PMID:
7051361
17.

Drug interactions with warfarin.

Hunninghake DB, Azarnoff DL.

Arch Intern Med. 1968 Apr;121(4):349-52. No abstract available.

PMID:
5645709
18.

[Laboratory control of the effect of anti-vitamins K on blood coagulation].

Langer B, Muraco B, Manasterski J, Bechara MJ, Sitrângulo Júnior C, Puech-Leão LE.

Rev Hosp Clin Fac Med Sao Paulo. 1984 Jan-Feb;39(1):12-7. Portuguese. No abstract available.

PMID:
6484435
19.

[Comparison between the dilution curves of prothrombin time and activated partial thromboplastin time for the control of the effect of anti-vitamin K].

Langer B, Fuess VL, Kauffman P, Bechara MJ, dos Reis JM, Kwang WT.

Rev Hosp Clin Fac Med Sao Paulo. 1984 Jan-Feb;39(1):18-22. Portuguese. No abstract available.

PMID:
6385200
20.

Potentiation of anticoagulant effect of warfarin by phenylbutazone.

Aggeler PM, O'Reilly RA, Leong L, Kowitz PE.

N Engl J Med. 1967 Mar 2;276(9):496-501. No abstract available.

PMID:
6018280

Supplemental Content

Support Center